EGFR and cancer: Thus, the peptides are most likely not binding to antigens that are expressed by several different types of cancer, such as the Thomsen–Friedenreich (TF) antigen, galectin-3, or the epidermal growth factor receptor (EGFR) [21,41,42,43,44].